HUTCHMED (China) (HCM) Profit After Tax (2015 - 2021)
HUTCHMED (China)'s (HCM) quarterly Profit After Tax came in at -$198.9 million in Q4 2021, down 234.39% on a QoQ basis from -$59.5 million in Q2 2021.
HUTCHMED (China) (HCM) Profit After Tax (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Profit After Tax data on file, last reported at -$198.9 million in Q4 2021.
- On a quarterly basis, Profit After Tax changed N/A year-over-year to -$198.9 million in Q4 2021; TTM through Dec 2021 was -$331.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $58.9 million, up 1103.08% from the prior year.
- Profit After Tax for Q4 2021 stood at -$198.9 million, down from -$59.5 million in the prior quarter.
- Over the last five years, Profit After Tax for HCM reached as high as $40.5 million in Q2 2018 and fell as low as -$198.9 million in Q4 2021.
- Historically, Profit After Tax has averaged -$29.1 million across 4 years, with a median of -$29.0 million in 2019.
- On a YoY basis, Profit After Tax climbed as much as 283.62% in 2019 and fell as far as 284.07% in 2019.
- Year by year, Profit After Tax stood at $15.7 million in 2018, then sank by 284.07% to -$29.0 million in 2019, then dropped by 13.22% to -$32.8 million in 2020, then slumped by 506.08% to -$198.9 million in 2021.
- Per Business Quant data, the three most recent Profit After Tax figures were -$198.9 million in Q4 2021, -$59.5 million in Q2 2021, and -$39.9 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | HUTCHMED (China) | 9.45 Bn | 9.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -198.92 Mn |
| Jun 30, 2021 | -59.49 Mn |
| Mar 31, 2021 | -39.85 Mn |
| Jun 30, 2020 | -32.82 Mn |
| Mar 31, 2020 | -15.43 Mn |
| Dec 31, 2019 | -28.99 Mn |
| Sep 30, 2019 | -31.24 Mn |
| Jun 30, 2019 | -62.56 Mn |
| Mar 31, 2019 | 19.11 Mn |
| Dec 31, 2018 | 15.75 Mn |
| Sep 30, 2018 | 25.41 Mn |
| Jun 30, 2018 | 40.53 Mn |
| Mar 31, 2018 | -10.41 Mn |
| Jun 30, 2016 | 29.56 Mn |
| Jun 30, 2015 | 23.49 Mn |